[1]王方平,张平安,牛志立.miRNA-122与丙肝病毒感染及肝癌关系的研究进展[J].现代检验医学杂志,2016,31(05):157-159，164.[doi:10.3969/j.issn.1671-7414.2016.05.047]
　WANG Fang-ping,ZHANG Ping-an,NIU Zhi-li.Studies About the Relationship between miR-122 and Hepatitis C Virus and Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(05):157-159，164.[doi:10.3969/j.issn.1671-7414.2016.05.047]
点击复制

miRNA-122与丙肝病毒感染及肝癌关系的研究进展()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年05期
页码:
157-159，164
栏目:
综述
出版日期:
2016-10-21

文章信息/Info

Title:
Studies About the Relationship between miR-122 and Hepatitis C Virus and Hepatocellular Carcinoma
文章编号:
1671-7414(2016)05-157-04
作者:
王方平; 张平安; 牛志立
武汉大学人民医院检验科,武汉 430060
Author(s):
WANG Fang-ping; ZHANG Ping-an; NIU Zhi-li
Department of Laboratory Science,Renmin Hospital of Wuhan University,Wuhan 430060,China
关键词:
微小RNA-122;  丙肝病毒;  肝癌
分类号:
R512.63; R735.7
DOI:
10.3969/j.issn.1671-7414.2016.05.047
摘要:
丙型肝炎病毒(hepatitis C virus,HCV)感染机体后易发展为肝炎、肝硬化及肝癌。目前,传统治疗方法为聚乙二醇干扰素联合利巴韦林,其效果不佳且副作用大,而新型直接抗病毒药物价格昂贵。因此,寻求廉价而无毒副作用的抗HCV感染治疗方法是目前研究的重点。越来越多的证据表明,微小核糖核酸(micro-ribose nucleicacid,miRNAs)在肝脏疾病发展、肝细胞再生和功能调节等方面发挥着重要的作用。该文就miR-122与丙肝病毒感染及肝癌关系的研究现状作一综述。
Abstract:
Hepatitis C virus(HCV)was easily developed into hepatitis,cirrhosis and liver cancer after infecting human.Currently,the traditional method of treatment of HCV was pegylated interferon and ribavirin program,which was ineffective and had poor side effects,while the new direct antiviral drugs were expensive.Therefore,looking for cheap and non-toxic side effects of treatment was the focus of current research.More and more evidence indicate that micro-Ribose Nucleic Acid(miRNAs)play an important role in the development of liver disease,regeneration and functional regulation.This review studies the relationship between miR-122 and Hepatitis C virus and hepatocellularcarcinoma.

参考文献/References:

[1] Javed F, Manzoor S, Khattak AA,et al.Molecular characterization and fluorescence analysis of HCV non-structural proteins NS3,NS3-4A and NS4A of genotype 3a[J].Acta Virol,2015,59(3):284-294.
[2] Mohd Hanafiah K, Groeger J, Flaxman AD,et al.Global epidemiology of hepatitis C virus infection:new estimates of age-specific antibody to HCV seroprevalence[J].Hepatology,2013,57(4):1333-1342.
[3] Aman W,Mousa S,Shiha G,et al.Current status and future directions inthe management of chronic hepatitis C[J].Virology Journal,2012(9):57.
[4] Lavanchy D.The global burden of hepatitis C[J].Liver Int,2009,29(Suppl1):74-81.
[5] Chen Y,Verfaillie CM.MicroRNAs:the fine modulators of liver development and function[J].Liver Int,2014,34(7):976-990.
[6] Friedman RC,Farh KK,Burge CB,et al.Most mammalian mRNAs are conservedtargets of microRNAs[J].Genome Res,2009,19(1):92-105.
[7] Tsang JS,Ebert MS,van Oudenaarden A.Genome-wide dissection of microRN-A functions and cotargeting networks using gene set signatures[J].Mol Cell,2010,38(1):140-153.
[8] Gao FB.Context-dependent functions of specific microRN-As in neuronaldevelopment[J].Neural Dev,2010(5):25.
[9] Yang B,Lin H,Xiao J,et al.The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2[J].Nat Med,2007,13(4):486-491.
[10] Small EM,Olson EN.Pervasive roles of microRNA-s in cardiovascular biology[J].Nature,2011,469(7330):336-342.
[11] O'Connell RM,Chaudhuri AA,Rao DS,et al.Inositol phosphatase SHIP1 is a primary target of miR-155[J].Proc Natl Acad Sci USA,2009,106(17):7113-7118.
[12] O'Connell RM,Rao DS,Chaudhuri AA,et al.Physiological and pathological roles for microRNAs in the immune system[J].Nat Rev Immunol,2010,10(2):111-122.
[13] Chiche J,Pommier S,Beneteau M,et al.GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependentinduction of HIF-1α[J].Leukemia,2015,29(5):1163-1176.
[14] Bandiera S,Hatem E,Lyonnet S,et al.MicroRNAs in diseases:from candidate to modifier genes[J].Clin Genet,2010,77(4):306-313.
[15] Hrdlickova B,de Almeida RC,Borek Z,et al.Genetic variation in the non-coding genome:involvement of micro-RNAs and long non-coding RNAs in disease[J].Biochim Biophys Acta,2014,1842(10):1910-1922.
[16] McManus DD,Freedman JE.MicroRNAs in platelet function and cardiovascular disease[J].Nat Rev Cardiol,2015,12(12):711-717.
[17] Feiersinger F, Nolte E, Wach S,et al.MiRNA-21 expression decreasesfrom primary tumors to liver metastases in colorectal carcinoma[J].PLoS One,2016,11(2):e0148580.
[18] Dong H,Lei J,Ding L,et al.MicroRNA:function,detection,and bioanalysis[J].Chem Rev,2013,113(8):6207-6233.
[19] Gupta P,Cairns MJ,Saksena NK.Regulation of ge-ne expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma[J].Imperial College London,2014,11(4):1-14.
[20] Luna JM,Scheel TK,Danino T,et al.Hepatitis C virus RNA functionallysequesters miR-122[J].Cell,2015,160(6):1099-1110.
[21] Jopling CL,Yi M,Lancaster AM,et al.Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA[J].Science(New York,N.Y),2005,309(5740):1577-1581.
[22] Li Y,Masaki T,Shimakami T,et al.hnRNP L and NF90 interact with hepatitis C virus 5'-terminal untranslated RNA and promote efficient replication[J].J Virol,2014,88(13):7199-7209.
[23] Janssen HL, Reesink HW, Lawitz EJ,et al.Treatment of HCV infection by targeting microRNA[J].N Engl J Med,2013,368(18):1685-1694.
[24] 晋 云,江 行,卿德科,等.MiR-122在肝细胞癌中的表达及其与肿瘤表型标志物的相关性研究[J].中华临床医师杂志(电子版),2013,7(24):11259-11262. Jin Y,Jiang X,Qing DK,et al.Study of correlation between the expression of mir-122 and phenotype marker[J].Chin J Clinicians(Electronic Edition),2013,24(11):11259-11262.
[25] Tsai WC,Hsu PW,Lai TC,et al.MicroRNA-122,a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma[J].Hepatology,2009,49(5):1571-1582.
[26] Nakao K,Miyaaki H,Ichikawa T.Antitumor function of microRNA-122 against hepatocellular carcinoma[J].J Gastroenterol,2014,49(4):589-593.
[27] Hsu SH,Wang B,Kota J,et al.Essential metabolic,anti-inflammatory,and anti-tumorigenic functions of miR-122 in liver[J].J Clin Invest,2012,122(8):2871-2883.
[28] Li J,Ghazwani M,Zhang Y,et al.MiR-122 regulates collagen productionvia targeting hepatic stellate cells and suppressing P4HA1 expression[J].J Hepatol,2013,58(3):522-528.
[29] Spaniel C,Honda M,Selitsky SR,et al.MicroRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection[J].PLoS One,2013,8(10):e76867.

相似文献/References:

[1]林 艳,但汉良,余 扬,等.慢性心力衰竭患者血清miR-122 和miR-558 水平表达与心功能及心率变异性的相关性研究[J].现代检验医学杂志,2024,39(03):37.[doi:10.3969/j.issn.1671-7414.2024.03.006]
　LIN Yan,DAN Hanliang,YU Yang,et al.Correlation between Serum miR-122 and miR-558 Levels and Cardiac Function and Heart Rate Variability in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2024,39(05):37.[doi:10.3969/j.issn.1671-7414.2024.03.006]

备注/Memo

备注/Memo:

作者简介:王方平(1989-),女,在读研究生,主要从事临床感染及免疫学研究。
通讯作者:张平安,E-mail:zhangpingan@aliyun.com。
更新日期/Last Update: 2016-10-30